|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Yasmin Werner at 2026-10-11 15:54
Sentiment: Negative
TLDR Novo Nordisk stock plunges over 9% after ZEUS misses its key heart trial goal. ZEUS shows lower inflammation but no reduction in major cardiovascular events. Ziltivekimab records a 0.99 hazard ratio against placebo in the phase 3 trial. Serious infection rates rise with treatment while overall mortality stays level. HERMES and ARTEMIS continue with [...] The post Novo Nordisk (NVO) Stock: Plunges 9% After ZEUS Heart Trial Misses Key Goal appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central